Health Reading List | September 18, 2015 | Startup Highlight: SimX
AR and VR have some pretty interesting implications for medicine, specifically around education and simulation. SimX has been around for some time, but has some of the most compelling technology out there bringing cheaper, more reliably simulation technology to teaching institutions.
As always, if you come across news, announcements, videos, or podcasts that you think everyone else would benefit from, e-mail me at scott.munro@startupdigestmail.com or tweet @R_Scott_Munro. | Global Startup Battle is back for 2015! Global Startup Battle 2015 is happening Nov 13-23! Host a Startup Weekend and add your city to the world’s largest startup competition with over 30,000 entrepreneurs, mentors, and judges: globalstartupbattle.co. | | There have been a number of analyses out there of investment in digital health, namely from Startup Health and Rock Health. Brookings weighed in, check out their study here. | | Biotech investments are notoriously risky relative to tech generally, so it's great to hear one of the best investors of our time discuss how he thinks about investing in the space. | | Another great interview from Startup Health, "Dr. Douglas Wood discusses how his strategy behind innovating to help patients better make decisions about their health and what the future looks like for health innovation." | | Pharma companies are continuing to evoke First Amendment rights as they push for Off Label discussions. The Boston Globe discusses how this issue has evolved over time and the latest suit from Pacira. | | Glenn D. Steele, Jr., MD discusses how he changed physician compensation at Geisinger in order to improve outcomes. A great read from HBR. | | | You are receiving this email because you believe that the best startup articles and videos are made by active members of the startup community. Startup Digest, © 2009-2015 by Techstars Central LLC. All rights reserved. Startup Digest is a registered trademark of Techstars Central, LLC. Privacy Policy. | | |
No comments:
Post a Comment